Schedule 13D ownership disclosure
CADUS PHARMACEUTICAL CORP
Security class unavailable · CUSIP: 127639102
Event date: 2014-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,653,193
- Percent of class
- 29.1100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000928464-14-000060
- Form type
- SC 13D
- Filer
- CADUS CORP
- CIK
- CIK 911148
- Filed
- Jun 09, 2014
- Reporting period
- Jun 06, 2014
- Description
- Schedule 13D beneficial ownership